Mark Erlander
CIK: 0001651537
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRDF
Cardiff Oncology, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Erlander Mark
Erlander Mark (SEC CIK 0001651537) files insider reports with the SEC as Chief Executive Officer of Cardiff Oncology, Inc. (CRDF).
Signal8 holds 1 ownership filing by Erlander Mark, a Form 4, filed on Mar 13, 2025. Those filings report 1 transaction, the latest on Mar 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Erlander Mark's filings is in SAN DIEGO, CA.
Recent filings by Erlander Mark
- Mar 11, 2025: Grant or award of CRDF derivative securities (Form 4, code A).
Other insiders filing for Cardiff Oncology, Inc. (CRDF)
- Alland Leila, Chief Medical Officer
- PACE GARY W, Director
- Mohindru Mani, Chief Executive Officer
- Armitage James O, Director
- White Lale, Director
- TANNENBAUM RENEE P, Director